Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2023/04/052081
CTRI/2023/04/052081
Completed
未知

A randomized, double-blinded, controlled study to evaluate the efficacy of test products in providing skin moisturization and barrier protection for up to 24 hours in healthy subjects.

Abbott India Limited0 sites30 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Abbott India Limited
Enrollment
30
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
June 1, 2023
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • •1\. Healthy female subjects, as determined from a recent medical history.
  • •2\. Subjects in the age group of 18\-45 years (both ages inclusive).
  • •3\. Subjects who present normal to dry skin on the forearm (corneometer value of 35 as maximum)
  • •4\. Healthy skin in the test sites.
  • •5\. Subjects willing to give voluntary written informed consent and agree to come for regular follow\-up.
  • •6\. Subjects willing to abide by and comply with the study protocol.
  • •7\. Subjects who are willing not to participate in any other clinical study during participation in the current study.

Exclusion Criteria

  • •1\. Excessive hair on the test site
  • •2\. A known history or present condition of an allergic response to any cosmetic products.
  • •3\. Change personal nutrition habits as well as sports habits
  • •4\. Start or change their oral hormonal treatment or their oral contraception
  • •5\. Subject having active skin diseases (e.g., active atopic dermatitis, pigmented contact dermatitis or other cutaneous manifestations), which will interfere with the assessment.
  • •6\. Subjects on oral medications (e.g. steroids, anti\-oxidant) which will compromise the study.
  • •7\. Subjects had cancer in the last 10 years
  • •8\. Subjects with wounds, sunburn, scars, tattoos or piercings at the skin test site(s)
  • •9\. Subjects with application of ointments, creams etc. for antibacterial, anti\-allergic or immunosuppressive treatment of the skin at the test site(s)
  • •10\. Systemic treatment which may modify the cutaneous state on the day of inclusion or in the previous 30 days, including retinoid therapy.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
A study to evaluate skin moisturization.
CTRI/2023/05/052885Sami-Sabinsa Group Ltd30
Active, not recruiting
Not Applicable
A double-blind, randomized, uncontrolled study to evaluate inhibition of ovulation of two oral estradiol / drospirenone regimens in healthy young female volunteers over a period of 3 treatment cyclesThe trial will be performed in healthy female volunteers. The intended indication is female contraception.
EUCTR2007-004544-73-DEBayer Schering Pharma AG
Completed
Not Applicable
A randomized, double-blind and controlled study of clearing heat and resolving depression in the treatment of bipolar depression and fire heat depressioBipolar disorder
ITMCTR2200005825Beijing Anding Hospital, Capital Medical University
Recruiting
Phase 3
Study on the efficacy of Probiotics in the treatment of Asthma in children and adolescentsAsthma
RBR-7jsgnshHospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
Completed
Not Applicable
Continuous TAP blocks for major gynaecological surgeryPain after major gynaecological oncology surgeryCancer
ISRCTN60295543Joint Research Governance Office, Imperial College Healthcare Trust19